IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Neurodegenerative disease management

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

2.95

h-Index

2024-2025

 36

Rank

2024-2025

 5735

SJR

2024-2025

 0.896

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Neurodegenerative disease management
Abbreviation Neurodegener. dis. manag.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q2); Neurology (clinical) (Q2)
h-index 36
Overall Rank/Ranking 5735
SCImago Journal Rank (SJR) 0.896
Impact Score 2.95
Publisher Taylor and Francis Ltd.
Country United Kingdom
ISSN 17582024, 17582032
Best Quartile Q2
Coverage History 2014-2025




About Neurodegenerative disease management


Neurodegenerative disease management is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Neurology (clinical) (Q2). It is published by Taylor and Francis Ltd.. The overall rank of Neurodegenerative disease management is 5735. According to SCImago Journal Rank (SJR), this journal is ranked 0.896. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 36. The best quartile for this journal is Q2.

The ISSN of Neurodegenerative disease management journal is 17582024, 17582032. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Neurodegenerative disease management is cited by a total of 311 articles during the last 3 years (Preceding 2024).


Neurodegenerative disease management Impact IF 2024-2025


The Impact IF 2024 of Neurodegenerative disease management is 2.95, which is computed in 2025 as per its definition. Neurodegenerative disease management IF is increased by a factor of 0.36 and approximate percentage change is 13.9% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Neurodegenerative disease management Impact IF 2025 Prediction


Impact IF 2024 of Neurodegenerative disease management is 2.95. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Neurodegenerative disease management. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 2.95
2023 2.59
2022 2.18
2021 2.23
2020 2.27
2019 1.52
2018 1.51
2017 1.62
2016 1.55
2015 1.45
2014 0.00

Neurodegenerative disease management h-index


  Table Setting

Neurodegenerative disease management has an h-index of 36. It means 36 articles of this journal have more than 36 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Neurodegenerative disease management ISSN


The ISSN of Neurodegenerative disease management is 17582024, 17582032. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Neurodegenerative disease management Rank and SCImago Journal Rank (SJR)


The overall rank of Neurodegenerative disease management is 5735. According to SCImago Journal Rank (SJR), this journal is ranked 0.896. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Neurodegenerative disease management by Year


Year SJR
2025/2026 Coming Soon
2024 0.896
2023 0.618
2022 0.518
2021 0.487
2020 0.674
2019 0.550
2018 0.632
2017 0.706
2016 0.628
2015 0.490
2014

Ranking of Neurodegenerative disease management by Year


Year Ranking
2025/2026 Coming Soon
2024 5735
2023 8642
2022 10020
2021 10251
2020 7415
2019 9011
2018 7633
2017 6698
2016 7534
2015 9364
2014 32567

Neurodegenerative disease management Publisher


Table Setting

Neurodegenerative disease management is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2014-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Neurodegenerative disease management is Neurodegener. dis. manag.. This abbreviation ('Neurodegener. dis. manag.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Neurodegenerative disease management


If your research field is/are related to Medicine (miscellaneous) (Q2); Neurology (clinical) (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Neurodegenerative disease management?

Neurodegenerative disease management latest impact IF is 2.95. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 2.95 (2024) and 0.00 (2014), respectively, in the last 11 years. Moreover, its average IS is 1.81 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Neurodegenerative disease management?

The Neurodegenerative disease management has an SJR (SCImago Journal Rank) of 0.896, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.896 in 2024 and the lowest being in 2014. Furthermore, the average SJR of the Neurodegenerative disease management over the previous 11-year period stands at 1.81.


What's the latest h-index of the Neurodegenerative disease management?

The latest h-index of the Neurodegenerative disease management is 36.


Who's the publisher of the Neurodegenerative disease management?

The Neurodegenerative disease management is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.


What's the current ranking of the Neurodegenerative disease management?

The Neurodegenerative disease management is currently ranked 5735 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 5735 in 2024 and its lowest position of 32567 in 2014.


What's the abbreviation or short name for the Neurodegenerative disease management?

The standard ISO4 abbreviation for the Neurodegenerative disease management is Neurodegener. dis. manag..


Is the "Neurodegenerative disease management" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Neurodegenerative disease management is classified as a journal that the Taylor and Francis Ltd. publishes.


What's the scope or major areas of the Neurodegenerative disease management?

The Neurodegenerative disease management encompasses the following areas:

  • Medicine (miscellaneous)
  • Neurology (clinical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Neurodegenerative disease management?

The Neurodegenerative disease management is assigned the following International Standard Serial Numbers (ISSN): 17582024, 17582032.


What's the best quartile of the Neurodegenerative disease management?

The best quartile for the Neurodegenerative disease management is Q2 (2024).


What's the coverage history of the Neurodegenerative disease management?

The Neurodegenerative disease management coverage history can be summarized as follows: 2014-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division conference and proceedings 17477 16 0.00
Journal of Geriatric Physical Therapy journal 8686 Lippincott Williams and Wilkins Ltd. 53 1.55
Current Sociology journal 5151 SAGE Publications Ltd 86 3.02
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
Howard Journal of Communications journal 14582 Taylor and Francis Ltd. 42 1.27
Libyan Studies journal 21508 Cambridge University Press 10 0.14
European Surgery - Acta Chirurgica Austriaca journal 18136 Springer Medizin 25 0.68
Tekstilec trade journal 17340 University of Ljubljana Press 16 1.29
Oral Radiology journal 9860 Springer Japan 28 2.17
Proceedings of the Royal Society of Queensland journal 28017 Royal Society of Queensland 12 0.17

Check complete list




Year wise Impact Score (IS) of Neurodegenerative disease management

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 2.95
2023 2.59
2022 2.18
2021 2.23
2020 2.27
2019 1.52
2018 1.51
2017 1.62
2016 1.55
2015 1.45
2014 0.00



Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Research | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Nature Medicine
Nature Research | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

Physiological Reviews
American Physiological Society | United States

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Research | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd | United Kingdom

Brain
Oxford University Press | United Kingdom

Acta Neuropathologica
Springer Science and Business Media Deutschland GmbH | Germany

Sleep Medicine Reviews
W.B. Saunders Ltd | United Kingdom

Translational Neurodegeneration
BioMed Central Ltd | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

See All